SK15082003A3 - Spôsob prípravy amorfného cilastatínu sodného - Google Patents

Spôsob prípravy amorfného cilastatínu sodného Download PDF

Info

Publication number
SK15082003A3
SK15082003A3 SK1508-2003A SK15082003A SK15082003A3 SK 15082003 A3 SK15082003 A3 SK 15082003A3 SK 15082003 A SK15082003 A SK 15082003A SK 15082003 A3 SK15082003 A3 SK 15082003A3
Authority
SK
Slovakia
Prior art keywords
solvent
cilastatin
sodium
cilastatin sodium
solution
Prior art date
Application number
SK1508-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Yatendra Kumar
Om Dutt Tyagi
Amit Rohtagi
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of SK15082003A3 publication Critical patent/SK15082003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/04Methanol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
SK1508-2003A 2001-05-18 2002-05-17 Spôsob prípravy amorfného cilastatínu sodného SK15082003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN593DE2001 2001-05-18
PCT/IB2002/001696 WO2002094742A1 (en) 2001-05-18 2002-05-17 Process for the preparation of amorphous cilastatin sodium

Publications (1)

Publication Number Publication Date
SK15082003A3 true SK15082003A3 (sk) 2004-06-08

Family

ID=11097060

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1508-2003A SK15082003A3 (sk) 2001-05-18 2002-05-17 Spôsob prípravy amorfného cilastatínu sodného

Country Status (24)

Country Link
US (1) US20040152780A1 (no)
EP (1) EP1395530A4 (no)
JP (1) JP2004526805A (no)
KR (1) KR20040044409A (no)
CN (1) CN1522235A (no)
AP (2) AP1511A (no)
AR (1) AR036017A1 (no)
BG (1) BG108447A (no)
BR (1) BR0209843A (no)
CA (1) CA2447788A1 (no)
CZ (1) CZ20033352A3 (no)
EA (1) EA005947B1 (no)
EE (1) EE200300567A (no)
HR (1) HRP20031052A2 (no)
HU (1) HUP0400825A2 (no)
IL (1) IL158945A0 (no)
MX (1) MXPA03010547A (no)
NO (1) NO20035138D0 (no)
NZ (1) NZ529625A (no)
OA (1) OA12607A (no)
PL (1) PL367937A1 (no)
SK (1) SK15082003A3 (no)
WO (1) WO2002094742A1 (no)
ZA (1) ZA200309287B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402312B1 (en) 2005-11-09 2013-07-17 Orchid Chemicals&Pharmaceuticals Limited An improved process for the preparation of cilastatin acid
WO2011080648A1 (en) * 2010-01-01 2011-07-07 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of cilastatin sodium
CN102675175B (zh) * 2011-03-08 2014-02-19 深圳市海滨制药有限公司 一种西司他丁的分离纯化方法
US11324804B2 (en) 2016-11-18 2022-05-10 Sepsia Therapeutics, S.L. Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
EP0441371B1 (en) * 1990-02-08 1995-01-25 Sumitomo Chemical Company, Limited Process for preparing haloketo acid derivatives
US5166417A (en) * 1990-09-04 1992-11-24 Lonza Ltd. Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
CA2056840A1 (en) * 1990-12-17 1992-06-18 Thomas Meul Process for the production of dimethylcyclopropanecarboxylic acid
DE59209523D1 (de) * 1991-07-26 1998-11-19 Lonza Ag Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (no) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EA005947B1 (ru) 2005-08-25
MXPA03010547A (es) 2004-05-27
CN1522235A (zh) 2004-08-18
EA200301225A1 (ru) 2004-06-24
AR036017A1 (es) 2004-08-04
PL367937A1 (en) 2005-03-07
EE200300567A (et) 2004-04-15
EP1395530A1 (en) 2004-03-10
US20040152780A1 (en) 2004-08-05
NO20035138D0 (no) 2003-11-18
CA2447788A1 (en) 2002-11-28
BG108447A (en) 2005-03-31
AP2003002913A0 (en) 2003-12-31
OA12607A (en) 2006-06-08
CZ20033352A3 (en) 2004-06-16
HUP0400825A2 (hu) 2004-08-30
IL158945A0 (en) 2004-05-12
EP1395530A4 (en) 2006-01-18
BR0209843A (pt) 2004-08-24
HRP20031052A2 (en) 2004-06-30
KR20040044409A (ko) 2004-05-28
AP2003002912A0 (en) 2002-05-17
JP2004526805A (ja) 2004-09-02
ZA200309287B (en) 2004-07-22
NZ529625A (en) 2006-02-24
WO2002094742A1 (en) 2002-11-28
AP1511A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
CH648555A5 (fr) Ester d'un acide thiazolyl acetique.
CZ302082B6 (cs) Prostredek zahrnující krystalograficky stabilní amorfní cefalosporin a zpusob jeho výroby
JP4338401B2 (ja) 4−フェニル酪酸の合成
CA1121343A (fr) Procede de preparation d'une forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino thiazolyl acetamido cephalosporanique
CA1186682A (en) Crystalline salts of cefodizim and a process for their preparation
FI75571B (fi) Framstaellningsfoerfarande foer synnerligen kristalliniskt natriumcefoperazon.
SK15082003A3 (sk) Spôsob prípravy amorfného cilastatínu sodného
US7511135B2 (en) Method for manufacture of ceftiofur
JPH0240676B2 (no)
US11274164B2 (en) Method for the preparation of sulfobutylether beta cyclodextrin sodium
AU2002258073A1 (en) Process for the preparation of amorphous cilastatin sodium
CN103570618A (zh) 一种孟鲁司特钠盐的制备方法
CN110678075B (zh) 吡唑胺反应结晶
JPS5844082B2 (ja) ヘパリンの製法
JPS61145187A (ja) セフアロスポリン類
JPH11180948A (ja) S−(1,2− ジカルボキシエチル) グルタチオンの製造法
US6040445A (en) Acyclovir dihydrate sodium salt and the preparation thereof
JPH0157115B2 (no)
FI61517C (fi) Foerfarande foer framstaellning av 6-(d-(-)-alfa-amino-alfa-(p-hydroxifenylacetamido))penicillansyra
DK158673B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser.
JPS6097994A (ja) イソエフロトマイシン
JPH0158190B2 (no)
JPH04136001A (ja) β―シクロデキストリン・スルホンアミド誘導体のポリ硫酸エステル及びその製法
JPH0665254A (ja) セフォラニド誘導体
JP2005139098A (ja) 1−チオ−2−プロパノン誘導体及び5−メチル−5−チオメチルヒダントイン誘導体の製造方法

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure